| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/21/2001 | CN1063340C Glycosuria lowering capasule contg. pearl and Radix astragali and its prodn. method |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204291 Effective amount of l-carnitine. |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/20/2001 | US6204278 Anilide compounds, including use thereof in ACAT inhibitition |
| 03/20/2001 | US6204277 Treating diabetes |
| 03/20/2001 | US6204247 Reacting a leptin with 0.5-5 fold molar excess of edta dianhydride to to form a monomer or dimer |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204032 Method for producing pravastatin precursor, ML-236B |
| 03/20/2001 | US6203785 Poly(diallylamine)-based bile acid sequestrants |
| 03/20/2001 | CA2102429C Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018161A2 Process for the preparation of conjugated linoleic acid (cla) |
| 03/15/2001 | WO2001018052A1 Monomeric analogues of human insulin |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018013A1 Prodrugs for liver specific drug delivery |
| 03/15/2001 | WO2001017994A1 Oxazole ppar antagonists |
| 03/15/2001 | WO2001017989A2 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 03/15/2001 | WO2001017981A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 03/15/2001 | WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 03/15/2001 | WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 03/15/2001 | WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | WO2001017942A1 Amides as inhibitors for pyruvate dehydrogenase |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017541A1 Composition for extending post meal satiety |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017530A1 Iron chelators and uses thereof |
| 03/15/2001 | WO2001017525A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 03/15/2001 | WO2001017498A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2001017377A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 03/15/2001 | WO2001017374A1 Compositions comprising conjugated linoleic acid (cla) |
| 03/15/2001 | WO2001017370A1 Nutritional compositions |
| 03/15/2001 | WO2001017369A1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars' |
| 03/15/2001 | WO2001017366A1 Improving condition of elderly pets |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | WO2000049007A8 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 03/15/2001 | DE19943491A1 Verbesserte Komprimate Improved compressed |
| 03/15/2001 | DE19941559A1 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie Using Bissulfonamiden for the preparation of medicaments for the prophylaxis or treatment of Hyperlipidömie |
| 03/15/2001 | DE19941217A1 Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof |
| 03/15/2001 | DE19939044A1 Verwendung von Morphinanderivaten als Arzneimittel Use of morphinan derivatives as medicaments |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384028A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383731A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 03/15/2001 | CA2383721A1 Use of 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogues as iron chelators |
| 03/15/2001 | CA2383720A1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars" |
| 03/15/2001 | CA2383638A1 Monomeric analogues of human insulin |
| 03/15/2001 | CA2383523A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 03/15/2001 | CA2383086A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | CA2380763A1 Aminoalkoxy carbazoles for the treatment of cns diseases |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348067A1 Composition for extending post meal satiety |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082314A1 New dipeptidyl peptidase iv effectors |
| 03/14/2001 | EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/14/2001 | EP1082107A1 Controlled release lipoic acid |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082029A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption |
| 03/14/2001 | EP1082028A1 Matthiola seed oil, mixtures containing it and use thereof |
| 03/14/2001 | EP1082026A1 Compositions comprising phytosterol and/or phytostanol having enhenced solubility and dispersa |
| 03/14/2001 | EP1082022A1 Esterified and subsequently hydrogenated phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like |
| 03/14/2001 | EP0900185B1 Vitamin d analogs and methods of preparing these compounds |
| 03/14/2001 | EP0831817B1 Antigen-processing cell-targeted conjugates comprising a polyamino acid backbone and a non-steroidal anti-inflammatory agent |
| 03/14/2001 | EP0781278B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 03/14/2001 | EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1287492A Method for administering ASPB 28-human insulin |
| 03/14/2001 | CN1287491A Method for administering monomeric insulin analogs |
| 03/14/2001 | CN1287489A Lipase inhibiting polymers |
| 03/14/2001 | CN1287124A Recombined natural and new-type human insulin and its preparation |
| 03/14/2001 | CN1287117A Cycloene derivate, its producing process and its therapeutical use |